144 related articles for article (PubMed ID: 17443845)
1. Prevalidation of potential protein biomarkers in toxicology using iTRAQ reagent technology.
Glückmann M; Fella K; Waidelich D; Merkel D; Kruft V; Kramer PJ; Walter Y; Hellmann J; Karas M; Kröger M
Proteomics; 2007 May; 7(10):1564-74. PubMed ID: 17443845
[TBL] [Abstract][Full Text] [Related]
2. Use of two-dimensional gel electrophoresis in predictive toxicology: identification of potential early protein biomarkers in chemically induced hepatocarcinogenesis.
Fella K; Glückmann M; Hellmann J; Karas M; Kramer PJ; Kröger M
Proteomics; 2005 May; 5(7):1914-27. PubMed ID: 15816005
[TBL] [Abstract][Full Text] [Related]
3. [Toxicoproteomics: first experiences in a BMBF-study].
Kröger M; Hellmann J; Toldo L; Glückmann M; von Eiff B; Fella K; Kramer PJ
ALTEX; 2004; 21 Suppl 3():28-40. PubMed ID: 15057406
[TBL] [Abstract][Full Text] [Related]
4. Toxicogenomic analysis of N-nitrosomorpholine induced changes in rat liver: comparison of genomic and proteomic responses and anchoring to histopathological parameters.
Oberemm A; Ahr HJ; Bannasch P; Ellinger-Ziegelbauer H; Glückmann M; Hellmann J; Ittrich C; Kopp-Schneider A; Kramer PJ; Krause E; Kröger M; Kiss E; Richter-Reichhelm HB; Scholz G; Seemann K; Weimer M; Gundert-Remy U
Toxicol Appl Pharmacol; 2009 Dec; 241(2):230-45. PubMed ID: 19716841
[TBL] [Abstract][Full Text] [Related]
5. Comparison of software tools to improve the detection of carcinogen induced changes in the rat liver proteome by analyzing SELDI-TOF-MS spectra.
Beyer S; Walter Y; Hellmann J; Kramer PJ; Kopp-Schneider A; Kroeger M; Ittrich C
J Proteome Res; 2006 Feb; 5(2):254-61. PubMed ID: 16457590
[TBL] [Abstract][Full Text] [Related]
6. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
[TBL] [Abstract][Full Text] [Related]
7. Identification of biomarkers indicating cellular changes after treatment of neuronal cells with the C3 exoenzyme from Clostridium botulinum using the iTRAQ protocol and LC-MS/MS analysis.
Muetzelburg MV; Hofmann F; Just I; Pich A
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 May; 877(13):1344-51. PubMed ID: 19109081
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of differential protein expression in early process of pancreatic regeneration in pancreatectomized rats.
Yang M; Liu W; Wang CY; Liu T; Zhou F; Tao J; Wang Y; Li MT
Acta Pharmacol Sin; 2006 May; 27(5):568-78. PubMed ID: 16626512
[TBL] [Abstract][Full Text] [Related]
9. Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways.
Sun S; Lee NP; Poon RT; Fan ST; He QY; Lau GK; Luk JM
Liver Int; 2007 Oct; 27(8):1021-38. PubMed ID: 17845530
[TBL] [Abstract][Full Text] [Related]
10. Proteomic alteration in lung tissue of rats exposed to cigarette smoke.
Zhang S; Xu N; Nie J; Dong L; Li J; Tong J
Toxicol Lett; 2008 May; 178(3):191-6. PubMed ID: 18467043
[TBL] [Abstract][Full Text] [Related]
11. Subcellular proteome analysis unraveled annexin A2 related to immune liver fibrosis.
Zhang L; Peng X; Zhang Z; Feng Y; Jia X; Shi Y; Yang H; Zhang Z; Zhang X; Liu L; Yin L; Yuan Z
J Cell Biochem; 2010 May; 110(1):219-28. PubMed ID: 20225235
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of a "biomarker of toxicity" from the proteome of the paralytic shellfish toxin-producing dinoflagellate Alexandrium tamarense (Dinophyceae).
Chan LL; Sit WH; Lam PK; Hsieh DP; Hodgkiss IJ; Wan JM; Ho AY; Choi NM; Wang DZ; Dudgeon D
Proteomics; 2006 Jan; 6(2):654-66. PubMed ID: 16342137
[TBL] [Abstract][Full Text] [Related]
13. Proteomic analysis of protein expression in human tonsillar cancer: differentially expressed proteins characterize human tonsillar cancer.
Roblick UJ; Bader FG; Hammarstedt L; Habermann JK; Hellman U; Becker S; Sundmacker A; Gemoll T; Zimmermann K; Auer G; Munck-Wikland E
Acta Oncol; 2008; 47(8):1493-501. PubMed ID: 18759147
[TBL] [Abstract][Full Text] [Related]
14. iTRAQ-based quantitative analysis of protein mixtures with large fold change and dynamic range.
Casado-Vela J; Martínez-Esteso MJ; Rodriguez E; Borrás E; Elortza F; Bru-Martínez R
Proteomics; 2010 Jan; 10(2):343-7. PubMed ID: 20029838
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of urine in rats chronically exposed to fluoride.
Kobayashi CA; Leite Ade L; da Silva TL; dos Santos LD; Nogueira FC; Santos KS; de Oliveira RC; Palma MS; Domont GB; Buzalaf MA
J Biochem Mol Toxicol; 2011; 25(1):8-14. PubMed ID: 20665605
[TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis of hepatic protein profiles in rare minnow (Gobiocypris rarus) exposed to perfluorooctanoic acid.
Wei Y; Chan LL; Wang D; Zhang H; Wang J; Dai J
J Proteome Res; 2008 Apr; 7(4):1729-39. PubMed ID: 18303832
[TBL] [Abstract][Full Text] [Related]
17. Quantitative Proteome-Property Relationships (QPPRs). Part 1: finding biomarkers of organic drugs with mean Markov connectivity indices of spiral networks of blood mass spectra.
Cruz-Monteagudo M; Munteanu CR; Borges F; Cordeiro MN; Uriarte E; González-Díaz H
Bioorg Med Chem; 2008 Nov; 16(22):9684-93. PubMed ID: 18951807
[TBL] [Abstract][Full Text] [Related]
18. Search for potential markers for prostate cancer diagnosis, prognosis and treatment in clinical tissue specimens using amine-specific isobaric tagging (iTRAQ) with two-dimensional liquid chromatography and tandem mass spectrometry.
Garbis SD; Tyritzis SI; Roumeliotis T; Zerefos P; Giannopoulou EG; Vlahou A; Kossida S; Diaz J; Vourekas S; Tamvakopoulos C; Pavlakis K; Sanoudou D; Constantinides CA
J Proteome Res; 2008 Aug; 7(8):3146-58. PubMed ID: 18553995
[TBL] [Abstract][Full Text] [Related]
19. Proteomic profiling of acute cardiac allograft rejection.
Kienzl K; Sarg B; Golderer G; Obrist P; Werner ER; Werner-Felmayer G; Lindner H; Maglione M; Schneeberger S; Margreiter R; Brandacher G
Transplantation; 2009 Aug; 88(4):553-60. PubMed ID: 19696639
[TBL] [Abstract][Full Text] [Related]
20. Use of SELDI MS to discover and identify potential biomarkers of toxicity in InnoMed PredTox: a multi-site, multi-compound study.
Collins BC; Sposny A; McCarthy D; Brandenburg A; Woodbury R; Pennington SR; Gautier JC; Hewitt P; Gallagher WM
Proteomics; 2010 Apr; 10(8):1592-608. PubMed ID: 20162557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
